Safety, Tolerability and Pharmacokinetics of Bencycloquidium Bromide, a Novel Inhaled Anticholinergic Bronchodilator, in Healthy Subjects: Results from Phase I Studies-Reference-Cited by-同舟云学术

Safety, Tolerability and Pharmacokinetics of Bencycloquidium Bromide, a Novel Inhaled Anticholinergic Bronchodilator, in Healthy Subjects: Results from Phase I Studies

Published:2021-02 Issue: Volume:157 Page:105646
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Luo Zhu,Hu Chao,Pan Yuanyuan,Miao Jia,Wang Ying,Ding Li,Liang Maozhi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference22 articles.

1. In vitro metabolism of bencycloquidium bromide and its inhibitory effects on human P450 isoenzymes: implication of CYP2D6, CYP2C19 and CYP3A4/5;Agbokponto;European journal of drug metabolism and pharmacokinetics,2016

2. M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice;Cao;European journal of pharmacology,2011

3. Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD;D'Urzo;International journal of chronic obstructive pulmonary disease,2018

4. Society ER. European Lung White Book, (2013) http://www.erswhitebook.org/, Accessed date: 5 February 2019.

5. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide;Gavalda;Pulmonary pharmacology & therapeutics,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methacholine Could Induce Asthma-Like Changes at the Molecular Level;J BIOL REG HOMEOS AG;2024

2. Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects;Frontiers in Pharmacology;2022-12-15

3. Research Advances in COPD Drugs and Novel Targets;Nano LIFE;2021-09